About
Nereus Pharmaceuticals develops and markets NEREUS™, an FDA-approved prescription NK1 receptor antagonist medication used to prevent vomiting induced by motion in adults.
Explore Nereus Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.